Chlorine in PDB 5a5j: Cytochrome 2C9 P450 Inhibitor Complex

All present enzymatic activity of Cytochrome 2C9 P450 Inhibitor Complex:
1.14.99.38;

The structure of Cytochrome 2C9 P450 Inhibitor Complex, PDB code: 5a5j was solved by S.E.Skerratt, M.J.De Groot, C.Phillips, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	71.74 / 2.90
Space group	H 3
Cell size a, b, c (Å), α, β, γ (°)	91.290, 91.290, 169.370, 90.00, 90.00, 120.00
R / Rfree (%)	21.303 / 28.792

The structure of Cytochrome 2C9 P450 Inhibitor Complex also contains other interesting chemical elements:

Fluorine	(F)	3 atoms
Iron	(Fe)	1 atom

The binding sites of Chlorine atom in the Cytochrome 2C9 P450 Inhibitor Complex (pdb code 5a5j). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Cytochrome 2C9 P450 Inhibitor Complex, PDB code: 5a5j:

Chlorine binding site 1 out of 1 in the Cytochrome 2C9 P450 Inhibitor Complex


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Cytochrome 2C9 P450 Inhibitor Complex within 5.0Å range: probe atom residue distance (Å) B Occ A:Cl1494 b:59.8 occ:1.00 CL A:6YF1494 0.0 59.8 1.0 C26 A:6YF1494 1.7 56.3 1.0 C23 A:6YF1494 2.7 55.6 1.0 C28 A:6YF1494 2.8 57.4 1.0 C24 A:6YF1494 3.0 57.3 1.0 OG1 A:THR304 3.0 24.0 1.0 CG A:GLU300 3.6 21.8 1.0 O A:GLU300 3.6 21.1 1.0 N25 A:6YF1494 3.7 60.2 1.0 C A:GLU300 3.8 22.3 1.0 CB A:ALA477 3.8 32.8 1.0 CB A:THR304 3.9 25.3 1.0 N A:THR301 3.9 22.1 1.0 C22 A:6YF1494 4.0 54.9 1.0 C20 A:6YF1494 4.1 56.9 1.0 CB A:GLU300 4.1 22.2 1.0 CA A:THR301 4.1 23.0 1.0 CG2 A:THR304 4.2 26.2 1.0 CD1 A:LEU361 4.2 18.9 1.0 CA A:GLU300 4.6 22.8 1.0 C21 A:6YF1494 4.6 55.1 1.0 CG2 A:VAL479 4.7 27.2 1.0 CD A:GLU300 4.7 20.1 1.0 CG2 A:THR301 4.7 23.5 1.0 OE2 A:GLU300 4.8 17.2 1.0 CG A:LEU361 4.9 18.2 1.0

S.E.Skerratt, M.J.De Groot, C.Phillips. Discovery of A Novel Binding Pocket For Cyp 2C9 Inhibitors: Crystallography, Pharmacophore Modelling and Inhibitor Sar. To Be Published.